← Back to all trials
Recruiting
NCT06974266
An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia
Conditions: Hypercholesterolaemia
Sex: All
Ages: 35 Years – 75 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Moon (Guangzhou) Biotechnology Co., Ltd.
Location: PKUCare Luzhong Hospital Zibo Shandong
Summary
The purpose of this study was to assess the safety and efficacy of AKM Lab-01 in subjects with hypercholesterolemia. This study will be conducted as a randomized, double-blind, placebo-controlled trial, eligible hypercholesterolemic participants were administered daily oral doses of either AKM Lab-01 or a placebo. Baseline clinical parameters, blood samples, and stool specimens were collected before and after the intervention for comparative analysis.
Eligibility Criteria
Inclusion Criteria:
1. Aged 35-75 years (inclusive), regardless of gender;
2. Patients diagnosed with hypercholesterolemia (5.2 mmol/L ≤ TC \
Source: ClinicalTrials.gov (NCT06974266). StuddyBuddy aggregates publicly available trial information.
